Lin Man

Lin Man is a declared insider of Beijing Tong Ren Tang Chinese Medicine Co. Ltd., with filings sourced from HKEX. The record holds 4 filings, for trades running from 4 July 2018 to 16 August 2022.

On the market, this insider has only ever bought: 4 purchases, €114k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2022, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €22k. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 75% of cases; the median change was +3.8%. They describe history only and say nothing certain about the share price ahead.

On 17 August 2022 came the latest disclosure, an open-market purchase for €23k in Beijing Tong Ren Tang Chinese Medicine Co. Ltd. Most trades are made public on the day they happen. That lag is the time during which only the insider knows about the trade. This summary is built from HKEX disclosures alone and does not predict where the share price will go.